THE DESK / CORRESPONDENCE
Contact the editorial desk
Corrections, new trial readouts, and citations that belong on the list.
Editorial correspondence
This desk keeps a register of what is missing from a literature, which means it goes out of date in a specific and predictable way: every time a trial reports, a gap recorded here either narrows or closes. Notes about newly published results are therefore the most valuable messages it receives, particularly from the ongoing retatrutide outcome programme [8], from any controlled human trial of BPC-157 [2], and from any tissue-level measurement of NAD+ [13].
Corrections are equally welcome. A figure quoted loosely, a study characterised more strongly than its design supports, a regulatory status that has moved, or a citation that belongs on the references page and is not there. A message is easiest to act on when it names three things: the page, the exact sentence in question, and the source that settles it, with an identifier where one exists.
Editorial mailbox: editors@checkedpeptides.com
What this desk cannot help with
So that no message sits unanswered for the wrong reason, a few requests fall outside what an independent literature digest can do.
- It cannot advise on, endorse or comment on human use of any compound covered here.
- It cannot suggest an amount, a schedule or a route for anyone, whatever the circumstances.
- It cannot recommend, review, verify or name a supplier, and it does not evaluate products.
- It cannot interpret an individual's symptoms, results or medical history, which requires a clinician with access to the person.
Anything on this site that concerns a real decision about health belongs in a conversation with a qualified professional, not in an inbox. What this desk can do is say precisely what has been published, what has not, and which study would settle the difference.